The term 'chitinosans' embraces the spectrum of acetylated poly(N-glucosami
nes) ranging from chitin to chitosan. Chitinosans (I), at acidic pH, have p
rotonated amines which can interact with oppositely charged drug ions and,
thereby, modify drug release from drug delivery systems. Tablets were compr
essed from a physical mixture containing salicylic acid (II) as the model d
rug, I, and magnesium stearate. Five commercial I compounds, varying in deg
ree of deacetylation and molecular weight, were selected. Tablets were comp
ressed at 5000, 10000, and 15000 psig using a Carver and a single punch tab
let press. The differential scanning calorimetry thermograms provided evide
nce of I-Il interaction in the powder blend. Analysis of variance (ANOVA) i
ndicated that the compression pressure did not significantly affect the cru
shing strength (CS) or the release profile of II from the I-matrix tablets
(P > 0.05). Furthermore, the ANOVA also indicated that the tablet press use
d during manufacture did not affect the above properties (P > 0.05); howeve
r, the chitinosans significantly affected the CS as well as the release pro
file of II from I-matrix tablets (P < 0.05). This study provides further ev
idence for the use of commercial I compounds as excipients for use in modif
ied release drug delivery systems. (C) 1999 Elsevier Science B.V. All right
s reserved.